Katherine Hardy
Family · Anchorage, AKNPI 1225032915
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,833 and has fallen 94.0% since, to $111 in 2025. Among family clinicians in AK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$673
- GSK$464
- AstraZeneca$400
- Astellas Pharma US Inc$270
- Genentech USA, Inc.$190
- Novo Nordisk$187
- plus $951 from 19 others
What the payments were for
- Food & beverage$3,135100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 35 | $673 |
| GSK | 19 | $464 |
| AstraZeneca | 20 | $400 |
| Astellas Pharma US Inc | 9 | $270 |
| Genentech USA, Inc. | 2 | $190 |
| Novo Nordisk | 11 | $187 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $140 |
| Sanofi | 1 | $81 |
| E.r. Squibb & Sons, L.L.C. | 5 | $73 |
| Lilly USA, LLC | 5 | $65 |
| Sanofi-aventis U.S. LLC | 3 | $64 |
| Eisai Inc. | 5 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Boehringer Ingelheim | 2 | $55 |
| Amgen | 3 | $50 |
| Nestle Healthcare Nutrition Inc. | 2 | $47 |
| Amarin Pharma, Inc. | 2 | $41 |
| Pfizer | 3 | $41 |
| Atricure, Inc. | 1 | $40 |
| Johnson & Johnson | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Bayer | 1 | $23 |
| Merck | 1 | $19 |
| Abbott | 1 | $19 |
| Novartis | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$122
- FARXIGA$118
- Veozah$116
- XOLAIR$111
How this compares
$3,135 in reported general payments places this provider in the 90th percentile of 315 family providers in Alaska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $105 |
Paid to pharmacies, not to this prescriber.
Other family in Anchorage
- Erica HeagyAnchorage$249K
- Trisha KernodleAnchorage$60K
- Marisha DietersAnchorage$6K
- Christine HooverAnchorage$6K
- Leigh KeeferAnchorage$5K
- Sara GeraciAnchorage$4K
- Christine SaganAnchorage$4K
- Bethany BuchananAnchorage$4K
- Natasha SherrillAnchorage$4K
- Andrea BirchAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.